CLINICAL_TRIALS
research
· 2026-03-30
Clinical Trial Update: Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer [Phase 3]
Summary
Phase 3 clinical trial comparing salvage moderate hypofractionated versus ultrahypofractionated radiotherapy for biochemical recurrence after radical prostatect…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Samsung Medical Center | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING